Armata Pharmaceuticals earnings were -$426.0k for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ARMP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$6.5M, down 351.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARMP reported annual earnings of -$18.9M, with -72.6% growth.
Armata Pharmaceuticals Earnings Reports & History FAQ
What were Armata Pharmaceuticals's earnings last quarter?
On ARMP's earnings call on Invalid Date, Armata Pharmaceuticals (NYSEMKT: ARMP) reported Q1 2025 earnings per share (EPS) of -$0.18, up 73.91% year over year. Total ARMP earnings for the quarter were -$6.53 million. In the same quarter last year, Armata Pharmaceuticals's earnings per share (EPS) was -$0.69.
Is Armata Pharmaceuticals profitable or losing money?
As of the last Armata Pharmaceuticals earnings report, Armata Pharmaceuticals is currently losing money. Armata Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$426.00 thousand, a 99.46% decrease year over year.
What was ARMP's earnings growth in the past year?
As of Armata Pharmaceuticals's earnings date in Invalid Date, Armata Pharmaceuticals's earnings has grown year over year. ARMP earnings in the past year totalled -$426.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.